Regenerative Medicine Regulation: Global Issues and Argentine Opportunities

Shawn Harmon; Fabiana Arzuaga; Graeme Laurie

Regenerative Medicine Regulation: Global Issues and Argentine Opportunities

Shawn Harmon, Fabiana Arzuaga, Graeme Laurie

School of Law

Research output: Book/Report › Commissioned report

Abstract

Policy Brief 1:2011
Drawing on a 2-day interactive expert workshop held on 7-8 November 2011 at the ESRC Genomics Forum in Edinburgh under the Forum’s Bright Ideas Programme, and also drawing on interdisciplinary engagements between interested stakeholders in the Argentine and UK regenerative medicine field that have been ongoing for some four years, this Policy Brief explores key issues in the regulation of cellular products, and, drawing on the EU and UK experience, makes a number of recommendations for regulation in Argentina.

Original language	English
Publisher	AHRC Research Centre for Studies in Intellectual Property and Technology Law
Number of pages	6
Publication status	Published - 2011

Publication series

Name	SCRIPT Opinions
Publisher	AHRC Research Centre for Studies in Intellectual Property and Technology Law
No.	1: 2011

Access to Document

Harmon 2011 Regenerative Medicine Regulation- Global Issues and Argentine
© Harmon, S., Arzuaga, F., & Laurie, G. (2011). Regenerative Medicine Regulation: Global Issues and Argentine Opportunities. (SCRIPT Opinions; 1: 2011). AHRC Research Centre for Studies in Intellectual Property and Technology Law.
Final published version, 922 KB

http://www2.law.ed.ac.uk/ahrc/opinions/regenglobalarg.pdf

GET: Social Values: Governing emerging biotechnologies
Harmon, S.
ESRC
1/04/08 → 31/03/10
Project: Research
AHRC/SCRIPT: AHRC Research Centre for Studies in Intellectual Property and Technology Law
Laurie, G., Craufurd-Smith, R., Guadamuz, A., MacQueen, H., Schafer, B. & Waelde, C.
AHRC
1/04/07 → 30/06/12
Project: Research

Cite this

@book{284dd98970d4477e9e1ab34410d96aa8,

title = "Regenerative Medicine Regulation: Global Issues and Argentine Opportunities",

abstract = "Policy Brief 1:2011 Drawing on a 2-day interactive expert workshop held on 7-8 November 2011 at the ESRC Genomics Forum in Edinburgh under the Forum{\textquoteright}s Bright Ideas Programme, and also drawing on interdisciplinary engagements between interested stakeholders in the Argentine and UK regenerative medicine field that have been ongoing for some four years, this Policy Brief explores key issues in the regulation of cellular products, and, drawing on the EU and UK experience, makes a number of recommendations for regulation in Argentina.",

author = "Shawn Harmon and Fabiana Arzuaga and Graeme Laurie",

year = "2011",

language = "English",

series = "SCRIPT Opinions",

publisher = "AHRC Research Centre for Studies in Intellectual Property and Technology Law",

number = "1: 2011",

}

TY - BOOK

T1 - Regenerative Medicine Regulation

T2 - Global Issues and Argentine Opportunities

AU - Harmon, Shawn

AU - Arzuaga, Fabiana

AU - Laurie, Graeme

PY - 2011

Y1 - 2011

N2 - Policy Brief 1:2011 Drawing on a 2-day interactive expert workshop held on 7-8 November 2011 at the ESRC Genomics Forum in Edinburgh under the Forum’s Bright Ideas Programme, and also drawing on interdisciplinary engagements between interested stakeholders in the Argentine and UK regenerative medicine field that have been ongoing for some four years, this Policy Brief explores key issues in the regulation of cellular products, and, drawing on the EU and UK experience, makes a number of recommendations for regulation in Argentina.

AB - Policy Brief 1:2011 Drawing on a 2-day interactive expert workshop held on 7-8 November 2011 at the ESRC Genomics Forum in Edinburgh under the Forum’s Bright Ideas Programme, and also drawing on interdisciplinary engagements between interested stakeholders in the Argentine and UK regenerative medicine field that have been ongoing for some four years, this Policy Brief explores key issues in the regulation of cellular products, and, drawing on the EU and UK experience, makes a number of recommendations for regulation in Argentina.

M3 - Commissioned report

T3 - SCRIPT Opinions

BT - Regenerative Medicine Regulation

PB - AHRC Research Centre for Studies in Intellectual Property and Technology Law

ER -

Regenerative Medicine Regulation: Global Issues and Argentine Opportunities

Abstract

Publication series

Access to Document

Fingerprint

Projects

GET: Social Values: Governing emerging biotechnologies

AHRC/SCRIPT: AHRC Research Centre for Studies in Intellectual Property and Technology Law

Cite this